Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found.Results from the ESSENCE phase 3 clinical trial ...

A Connecticut man came home from Vietnam with lasting physical and mental scars. Now, 50 years later, he's still dealing with ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

To report SUSPECTED ADVERSE REACTIONS, contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or FDA at 1-800-FDA-1088 or ...

New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...